Safety, Feasibility Of Intravenous And Intrathecal Injection Of Autologous Bone Marrow Derived Mesenchymal Stromal Cells In Patients With Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial

Safety, Feasibility Of Intravenous And Intrathecal Injection Of Autologous Bone Marrow Derived Mesenchymal Stromal Cells In Patients With Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial

Objective Amyotrophic lateral sclerosis (ALS) is the most severe disorder within the spectrum of motor neuron diseases (MND) that has no effective treatment and a progressively fatal outcome. We have conducted two clinical trials to assess the safety and feasibility of intravenous (IV) and intrathe...

Full description

Bibliographic Details
Main Authors: Seyed Massood Nabavi, Leila Arab, Neda Jarooghi, Tina Bolurieh, Fatemeh Abbasi, Soura Mardpour, Vajihe Azimyian, Fatemeh Moeininia, Saman Maroufizadeh, Leila Sanjari, Seyedeh Esmat Hosseini, Nasser Aghdami
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2018-08-01
Series:Cell Journal
Subjects:
Amyotrophic Lateral Sclerosis
Bone Marrow
Intrathecal
Intravenous
Mesenchymal Stromal Cell
Online Access:https://celljournal.org/journal/article/abstract/5370

Internet

https://celljournal.org/journal/article/abstract/5370

Similar Items